proton pump inhibitor


Also found in: Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

proton pump inhibitor

n.
Any of a class of drugs that inhibit gastric acid secretion by interfering with the movement of hydrogen ions across cell membranes and are used mainly to treat peptic ulcers and gastroesophageal reflux disease.
References in periodicals archive ?
announced today that Eisai has obtained the approval of additional dosage and administration in Japan of the proton pump inhibitor Pariet 5 mg Tablets and 10 mg Tablets (generic name: rabeprazole sodium) to administer 10 mg of rabeprazole sodium per dose twice-daily for the maintenance therapy of proton pump inhibitor-resistant reflux esophagitis (reflux esophagitis in which it is difficult to achieve satisfactory therapeutic effects by existing treatment with once-daily dosing of proton pump inhibitors).
Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care.
Factors influencing compliance in long-term proton pump inhibitor therapy in general practice.
One aspect of the study analysis suggests twice-daily proton pump inhibitor dosing was associated with a 46% higher risk of chronic kidney disease than once-daily dosing, which was associated with a 15% higher risk.
Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis.
They suggested that blocking this pathway by complete acid suppression with a proton pump inhibitor, may reduce the risk of the cancer.
VIMOVO is a fixed-dose combination of delayed-release enteric-coated naproxen, a non-steroidal anti-inflammatory drug (NSAID), and immediate-release esomeprazole, a stomach acid-reducing proton pump inhibitor (PPI).
This concomitant therapy consists of a proton pump inhibitor, amoxicillin hydrate (generic name; marketed under two brand names), and either clarithromycin (generic named: marketed under two brand names) or metronidazole (generic name; marketed under one brand name).
Taking a protease inhibitor or a proton pump inhibitor (a drug that controls stomach acid) was linked to a higher risk of hip, spine, or upper arm fractures in a large study of HIV-positive US male veterans.
Of these 26,000 adults, 12 percent received a proton pump inhibitor with or without an H2-receptor antagonist for at least two years; 4.
Patients and Methods: Endoscopically diagnosed cases of duodenal ulcer were assigned to two groups where one group received herbal medicine and the other received proton pump inhibitor for 4 weeks (Clarithromycin and Amoxicillin were added for a week for Helicobacter pylori positive cases).
A proton pump inhibitor discovered by Takeda Pharmaceutical, Takepron is marketed in over 90 countries worldwide.